BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3183381)

  • 1. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
    Perez HD; Goldstein IM; Webster RO; Henson PM
    J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
    Doherty DE; Haslett C; Tonnesen MG; Henson PM
    J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD; Hooper C; Volanakis J; Ueda A
    J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
    Kew RR; Webster RO
    J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).
    Perez HD; Kelly E; Chenoweth D; Elfman F
    J Clin Invest; 1988 Jul; 82(1):360-3. PubMed ID: 3392212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
    Takematsu H; Tagami H
    Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
    Movat HZ; Rettl C; Burrowes CE; Johnston MG
    Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
    Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
    Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
    Robbins RA; Hamel FG
    J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte chemotaxis in systemic lupus erythematosus.
    Perez HD; Goldstein IM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():53-8. PubMed ID: 3612652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
    Tonnesen MG; Smedly LA; Henson PM
    J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human C5a des Arg increases vascular permeability.
    José PJ; Forrest MJ; Williams TJ
    J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.
    Okusawa S; Dinarello CA; Yancey KB; Endres S; Lawley TJ; Frank MM; Burke JF; Gelfand JA
    J Immunol; 1987 Oct; 139(8):2635-40. PubMed ID: 3116090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.